SCHEMBL11243876

SCHEMBL11243876

CN1CC(CCCl)N(c2ccccc2)C1=O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 2/20 0.36
▸ CYP2C9 P11712 2/20 0.36
▸ CYP2C19 P33261 2/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ NPSR1 Q6W5P4 2/20 0.36
▸ MEN1 O00255 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ BRD4 O60885 3/20 0.34
▸ GAA P10253 1/20 0.34
▸ G6PD P11413 1/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.34
▸ GRM2 Q14416 2/20 0.34
▸ LMNA P02545 1/20 0.34
▸ RECQL P46063 1/20 0.34
▸ PRKCA P17252 1/20 0.34
▸ GSK3B P49841 1/20 0.34
▸ RIPK1 Q13546 1/20 0.34
▸ P2RX7 Q99572 2/20 0.34
▸ NPC1 O15118 1/20 0.33
▸ RAB9A P51151 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11243561 0.82 SIGMAR1 (0.33) CYP1A2CYP2C9CYP2C19SMN1; SMN2NPSR1
SCHEMBL11246415 0.81 MEN1 (0.30) CYP1A2CYP2C9CYP2C19SMN1; SMN2NPSR1
SCHEMBL11246407 0.81 MEN1 (0.30) CYP1A2CYP2C9CYP2C19SMN1; SMN2NPSR1
Hydrochloric Acid SCHEMBL11233175 0.81 SIGMAR1 (0.33) CYP1A2CYP2C9CYP2C19SMN1; SMN2NPSR1
SCHEMBL9698946 0.80 CHRM2 (0.37) CYP1A2CYP2C9CYP2C19SMN1; SMN2NPSR1
SCHEMBL11238695 0.78 CYP1A2 (0.31) CYP1A2CYP2C9CYP2C19MEN1KMT2A
SCHEMBL11238705 0.78 CYP1A2 (0.31) CYP1A2CYP2C9CYP2C19MEN1KMT2A
SCHEMBL11232809 0.77 P2RX7 (0.35) KMT2ABRD4P2RX7
Fumaric Acid SCHEMBL11244743 0.75 PLA2G10 (0.34) SMN1; SMN2MEN1KMT2ALMNA
Fumaric Acid SCHEMBL11244739 0.75 PLA2G10 (0.34) SMN1; SMN2MEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4327098-A Pharmaceutical compositions useful in the treatment of cardiovascular hypertension and containing 4-substituted-2-iminoimadazolidine compounds A. H. ROBINS COMPANY, INC. (US) 1982-04-27 — — US disclosed
US-4327108-A Methods useful in the treatment of cardiac arrhythmia using 4-substituted-2-iminoimidazolidine compounds A. H. ROBINS COMPANY, INC. (US) 1982-04-27 — — US disclosed
US-4327107-A Method useful in the treatment of sugar cataracts using 4-substituted-2-iminoimidazolidine compounds A. H. ROBINS COMPANY, INC. (US) 1982-04-27 — — US disclosed
US-4288447-A Antihyperglycemic 4-substituted 2-iminoimidazolidine compositions A. H. ROBINS COMPANY, INC. (US) 1981-09-08 — — US disclosed
US-4288591-A ANTIINFLAMMATORY, HYPOTENSIVE, HYPOGLYCEMIC A. H. ROBINS COMPANY, INC. (US) 1981-09-08 — — US disclosed
US-4247705-A HYPOTENSIVE, HYPOGLYCEMIC, ANTIINFLAMMATORY A. H. ROBINS COMPANY, INC. (US) 1981-01-27 — — US disclosed
Send feedback